The Medicines and Healthcare products Regulatory Agency (MHRA) yesterday (November 13) said that a company has recalled two batches of EXS Delay Spray Plus, which is used to delay ejaculation.
This was done as a “precautionary measure” due to “limited information on the quantity of lidocaine present” in the spray, it added.
Read more: Pharmacists to identify beta blocker patients after packaging ‘mix-up’
Leeds Trading Company (LTC) Healthcare informed the MHRA that it has been “selling a medicinal product containing lidocaine without authorisation” from the medicines regulator, it said.
The product was recalled “on safety grounds” due to it not having “undergone the appropriate assessments related to safety, quality and efficacy”, it added.
Read more: Epilepsy pills recalled after patient finds ‘metallic particle’ inside
“This recall is to provide information to customers who may use or have used the product and to provide mitigation of any further supply of a product without the appropriate authorisation,” the MHRA said.
LTC Healthcare’s investigation is “ongoing” and “all remaining stock of the product” must be returned to the company, it added.
Stop supplying “immediately”
The alert advised pharmacies to stop supplying the affected batches “immediately”, quarantine “all remaining stock” and “liaise” with LTC Healthcare on the return process.
The company has “traceability of direct sales” and will contact distributors to “initiate recall action”, the MHRA said.
Read more: ‘Stop supplying immediately’: Pfizer recalls anaemia drug over ‘fatal events’
It advised patients to “stop using the product immediately” and “contact the company where [they] purchased the product from for details of their returns process”.
It added that they should “seek medical attention” if they experience an adverse reaction or have any questions and report “suspected” adverse reactions and “defects” to the MHRA Yellow Card scheme.
Read more: Multiple sclerosis drug recalled over unacceptable ‘variability’
The affected batches – both 50ml – are:
- DS29011024 – expiring January 2027
- DS24081023 – expiring August 2026
Meanwhile, a batch of beta blocker medicine was recalled last month (October 29) amid concerns that blister strips of a different medication could be inside the tablet pack.
And a batch of anti-seizure medicine was recalled in the same month after a patient discovered a small piece of metal inside a tablet.